Amphastar Pharmaceuticals, Inc. Annual Operating Income (Loss) in USD from 2012 to 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Amphastar Pharmaceuticals, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2012 to 2023.
  • Amphastar Pharmaceuticals, Inc. Operating Income (Loss) for the quarter ending June 30, 2024 was $55.2M, a 49.7% increase year-over-year.
  • Amphastar Pharmaceuticals, Inc. Operating Income (Loss) for the twelve months ending June 30, 2024 was $230M, a 75% increase year-over-year.
  • Amphastar Pharmaceuticals, Inc. annual Operating Income (Loss) for 2023 was $197M, a 83.2% increase from 2022.
  • Amphastar Pharmaceuticals, Inc. annual Operating Income (Loss) for 2022 was $107M, a 53.8% increase from 2021.
  • Amphastar Pharmaceuticals, Inc. annual Operating Income (Loss) for 2021 was $69.9M, a 538% increase from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $197M +$89.5M +83.2% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-29
2022 $107M +$37.6M +53.8% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-29
2021 $69.9M +$58.9M +538% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-29
2020 $11M +$11M Jan 1, 2020 Dec 31, 2020 10-K 2023-03-01
2019 -$39K +$8.58M +99.5% Jan 1, 2019 Dec 31, 2019 10-K 2022-03-11
2018 -$8.62M -$7.35M -580% Jan 1, 2018 Dec 31, 2018 10-K 2021-03-15
2017 -$1.27M -$16.6M -108% Jan 1, 2017 Dec 31, 2017 10-K 2020-03-16
2016 $15.4M +$22.3M Jan 1, 2016 Dec 31, 2016 10-K 2019-03-15
2015 -$6.9M +$11.1M +61.6% Jan 1, 2015 Dec 31, 2015 10-K 2018-03-14
2014 -$18M -$35.5M -203% Jan 1, 2014 Dec 31, 2014 10-K 2017-03-15
2013 $17.5M -$7.91M -31.1% Jan 1, 2013 Dec 31, 2013 10-K 2016-03-15
2012 $25.4M Jan 1, 2012 Dec 31, 2012 10-K 2015-03-26
* An asterisk sign (*) next to the value indicates that the value is likely invalid.